Cost ‐effectiveness of implementing molecular immunohematology
ConclusionMolecular immunohematology is not the implementation of cost reductions but the recognition of ‘effective’ processes and algorithms that incorporate molecular testing to provide tangible benefits to pregnant women and transfusion recipients.
Source: ISBT Science Series - Category: Hematology Authors: G. A. Denomme Tags: Congress Review Source Type: research
More News: Gammagard Liquid | Genetics | Hematology | History of Medicine | Molecular Biology | Politics | Pregnancy | Privigen | Science | Women